Joshua Brown, Pharm.D., Ph.D., M.S., an assistant professor of pharmaceutical outcomes and policy, has been appointed to the editorial board of the BMC Cardiovascular Disorders journal. His appointment is in the “non-coronary artery cardiac disease” section, one of five subject areas covered by the board. As an editorial board member, Brown will participate in the manuscript review process at all stages including the editorial decisions on manuscripts, identifying potential reviewers and communicating with authors.

BMC Cardiovascular Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of disorders of the heart and circulatory system, as well as related molecular and cell biology, genetics, pathophysiology, epidemiology and controlled trials. He credits this appointment to his work in cardiovascular diseases through grants from the U.S. Food and Drug Administration and the PhRMA Foundation, on which he has largely focused on treatment and prevention for thrombosis in atrial fibrillation and venous thromboembolism.

Brown has been appointed as an Editorial Advisory Board member for the Journal of Managed Care & Specialty Pharmacy, the flagship journal of the Academy of Managed Care Pharmacy, or AMCP, and will serve in that role until 2020 providing input on editorial content and service to the editorial board of that journal.

These service appointments are the first for Brown, who joined the college in 2016.